TAMPA, Fla., April 7, 2026 /PRNewswire/ -- TuHURA Biosciences, Inc. (NASDAQ:HURA) ("TuHURA" or the "Company"), a Phase 3 immuno-oncology company developing novel therapeutics to overcome resistance to ...

First patient dosed in Phase 1b portion of ongoing Phase 1 study evaluating PHST001 in combination with chemotherapyCompany to present three ...

NEW YORK, March 12, 2026 /PRNewswire/ -- ImmunoBrain, a clinical-stage biopharmaceutical company developing novel immunotherapies for neurodegenerative diseases, today announced that Phase 1b data for ...

Potential breakthrough therapeutic targets $50B+ global immunotherapy market1CHICAGO, March 31, 2026 (GLOBE NEWSWIRE) -- MAIA Biotechnology, ...

Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) ("Kiora" or the "Company") today announced financial results for the fourth ...

TEHRAN, Iran (AP) — Iranian officials on Tuesday urged young people to form human chains to protect power plants, as U.S.

The U.S. again struck the Iranian oil hub of Kharg Island, according to a White House official who was not authorized to speak publicly and spoke on condition of anonymity. The U.S. hit military ...

Iran has reportedly rejected a 45-day ceasefire proposal. Meanwhile, President Donald Trump's deadline to reopen the Strait ...

President Donald Trump has warned that a “whole civilization will die tonight” but said Iran still has time to capitulate ahead of a deadline set for 8 p.m. in Washington.